PolyProx Therapeutics polyprox.com


Public lists: Pharma Startups (6570)

PolyProx Therapeutics develops Polyproxin molecules, a class of drugs that are able to selectively target tumour cells and trigger the natural degradation machinery contained within the cell to arrest tumour growth.

PolyProx Therapeutics develops Polyproxin molecules, a class of drugs that are able to selectively target tumour cells and trigger the natural degradation machinery contained within the cell to arrest tumour growth.

Company (Alive / Active)

Phone: +44 (0)1223 804 420

Fax:

Building 580, Babraham Research Campus

Cambridge, CB22 3AT
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PolyProx Therapeutics $4.4M Apr 30, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PolyProx Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)